Biotech Analysts Minter and Schram, along with CEO Monia discuss the company’s clinical capabilities as a leader in the RNA-targeted therapeutics space with a focus on key near-term events on a conference call to be held on December 12 at 12:30 pm hosted by William Blair. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IONS:
- Ionis Pharmaceuticals participates in a conference call with William Blair
- Ionis Pharmaceuticals management to meet with Oppenheimer
- Ionis Pharmaceuticals files automatic common stock offering
- Ionis Pharmaceuticals management to meet with Needham
- Ionis shares clinical update from ongoing trial of ION582 for Angelman syndrome
